Colin Scibetta1, Kathleen Kerr2, Joseph Mcguire3, Michael W Rabow1. 1. 1 Department of Medicine, University of California , San Francisco, San Francisco, California. 2. 2 Kerr Healthcare Analytics , Mill Valley, California. 3. 3 UCSF Cancer Registry, University of California , San Francisco, San Francisco, California.
Abstract
BACKGROUND: Palliative care is recommended along with oncologic care for patients with advanced cancer. However, there are limited data about how the timing of palliative care affects quality and costs. OBJECTIVE: Comparison of health care utilization and care quality for patients with cancer who died having received early versus late palliative care. DESIGN: Analysis of cancer registry, administrative, and billing databases. SETTING/ SUBJECTS: Patients with cancer who died having received specialty palliative care consultation. MEASUREMENTS: Comparing early (more than 90 days prior to death) versus late (less than 90 days prior to death) palliative care, outcome measures included rates of health care utilization and health care costs. RESULTS: Among 922 decedents, 297 (32.2%) had palliative care referrals, with 93 (10.1%) receiving early referrals and 204 (22.1%) late referrals. Compared to patients receiving late palliative care, early palliative care patients had lower rates of inpatient (33% versus 66%, p < 0.01), ICU (5% versus 20%, p < 0.01), and ED utilization (34% versus 54%, p = 0.04) in the last month of life. Direct costs of inpatient care in the last 6 months of life for patients with early palliative care were lower compared to late palliative care ($19,067 versus $25,754, p < 0.01), while direct outpatient costs were similar ($13,040 versus $11,549, p = 0.85). Early palliative care was predominantly delivered in the outpatient setting (84%) while late palliative care was mostly delivered in the hospital (82%). CONCLUSIONS: Early palliative care is associated with less intensive medical care, improved quality outcomes, and cost savings at the end of life for patients with cancer. Despite recommendations that early palliative care be offered to all patients with metastatic cancer, palliative care services remain underutilized.
BACKGROUND: Palliative care is recommended along with oncologic care for patients with advanced cancer. However, there are limited data about how the timing of palliative care affects quality and costs. OBJECTIVE: Comparison of health care utilization and care quality for patients with cancer who died having received early versus late palliative care. DESIGN: Analysis of cancer registry, administrative, and billing databases. SETTING/ SUBJECTS:Patients with cancer who died having received specialty palliative care consultation. MEASUREMENTS: Comparing early (more than 90 days prior to death) versus late (less than 90 days prior to death) palliative care, outcome measures included rates of health care utilization and health care costs. RESULTS: Among 922 decedents, 297 (32.2%) had palliative care referrals, with 93 (10.1%) receiving early referrals and 204 (22.1%) late referrals. Compared to patients receiving late palliative care, early palliative care patients had lower rates of inpatient (33% versus 66%, p < 0.01), ICU (5% versus 20%, p < 0.01), and ED utilization (34% versus 54%, p = 0.04) in the last month of life. Direct costs of inpatient care in the last 6 months of life for patients with early palliative care were lower compared to late palliative care ($19,067 versus $25,754, p < 0.01), while direct outpatient costs were similar ($13,040 versus $11,549, p = 0.85). Early palliative care was predominantly delivered in the outpatient setting (84%) while late palliative care was mostly delivered in the hospital (82%). CONCLUSIONS: Early palliative care is associated with less intensive medical care, improved quality outcomes, and cost savings at the end of life for patients with cancer. Despite recommendations that early palliative care be offered to all patients with metastatic cancer, palliative care services remain underutilized.
Authors: Lisa D DiMartino; Bryan J Weiner; Laura C Hanson; Morris Weinberger; Sarah A Birken; Katherine Reeder-Hayes; Justin G Trogdon Journal: J Palliat Med Date: 2017-08-03 Impact factor: 2.947
Authors: Justin A Yu; Kristin N Ray; Seo Young Park; Amanda Barry; Cardinale B Smith; Peter G Ellis; Yael Schenker Journal: J Oncol Pract Date: 2018-11-08 Impact factor: 3.840
Authors: Anjali V Desai; Virginia M Klimek; Kimberly Chow; Andrew S Epstein; Camila Bernal; Kelly Anderson; Molly Okpako; Robin Rawlins-Duell; Dana Kramer; Danielle Romano; Jessica I Goldberg; Judith E Nelson Journal: J Oncol Pract Date: 2018-12 Impact factor: 3.840
Authors: Lisa D DiMartino; Bryan J Weiner; Laura C Hanson; Morris Weinberger; Sarah A Birken; Katherine Reeder-Hayes; Justin G Trogdon Journal: Healthc (Amst) Date: 2017-12-19
Authors: Kathleen Oare Lindell; Dio Kavalieratos; Kevin F Gibson; Laura Tycon; Margaret Rosenzweig Journal: Heart Lung Date: 2016-11-18 Impact factor: 2.210
Authors: Daniel P Triplett; Wendi G LeBrett; Alex K Bryant; Andrew R Bruggeman; Rayna K Matsuno; Lindsay Hwang; Isabel J Boero; Eric J Roeland; Heidi N Yeung; James D Murphy Journal: J Oncol Pract Date: 2017-08-22 Impact factor: 3.840
Authors: Sandhya Yadav; Isaac W Heller; Nancy Schaefer; Ramzi G Salloum; Sheri M Kittelson; Diana J Wilkie; Jinhai Huo Journal: Support Care Cancer Date: 2020-05-21 Impact factor: 3.603